Skip to content

Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema

Eczema

This exploratory study aims to verify the impact on the severity of eczema as well as the prebiotic potential of a daily application of Omega-3 serum and cream on a skin with eczema. This study will also collect data on possible adverse effects of the products. Sixteen participants will be enrolled in this study and will be divided in two groups of 8 subjects that will receive two different treatments for forty-two days. The baseline condition will serve as a control for the effects observed after treatment on the targeted eczema area.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

1. Participant aged of at least 18 years old.
2. Participant diagnosed with eczema who did not use corticosteroids in the 14 days prior to study day 1;
3. Available for the entire duration of the study and willing to participate based on the information provided in the ICF duly read and signed by the latter.
4. Participant without intellectual problems likely to limit the validity of consent to participate in the study and compliance with protocol requirements, having the ability to cooperate adequately, understand and observe the instructions of research staff.

Exclusion Criteria:

* None

Lieu de l'étude

SCF Pharma
SCF Pharma
Rimouski, Quebec
Canada

Contactez l'équipe d'étude

Primary Contact

Samuel Fortin, PhD

[email protected]
418-750-8590
Étude parrainée par
SCF Pharma
Participants recherchés
Plus d'informations
ID de l'étude: NCT06155513